KCNT2
Potassium channel subfamily T member 2
Also known as: KCa4.2, KCNT2_HUMAN, SLICK, SLO2.1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UVM3
- Gene
- KCNT2
- Ensembl
- ENSG00000162687
- Chromosome
- 1
- Canonical length
- 1135 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels
- Subcellular location
- Vesicles
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Enables chloride-activated potassium channel activity and intracellular sodium-activated potassium channel activity. Involved in potassium ion export across plasma membrane. Located in plasma membrane. Implicated in developmental and epileptic encephalopathy 57. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1135 residues, UniProt reviewed canonical sequence.
>Q6UVM3|KCNT2
1 MVDLESEVPP LPPRYRFRDL LLGDQGWQND DRVQVEFYMN ENTFKERLKL FFIKNQRSSL
61 RIRLFNFSLK LLSCLLYIIR VLLENPSQGN EWSHIFWVNR SLPLWGLQVS VALISLFETI
121 LLGYLSYKGN IWEQILRIPF ILEIINAVPF IISIFWPSLR NLFVPVFLNC WLAKHALENM
181 INDLHRAIQR TQSAMFNQVL ILISTLLCLI FTCICGIQHL ERIGKKLNLF DSLYFCIVTF
241 STVGFGDVTP ETWSSKLFVV AMICVALVVL PIQFEQLAYL WMERQKSGGN YSRHRAQTEK
301 HVVLCVSSLK IDLLMDFLNE FYAHPRLQDY YVVILCPTEM DVQVRRVLQI PMWSQRVIYL
361 QGSALKDQDL LRAKMDDAEA CFILSSRCEV DRTSSDHQTI LRAWAVKDFA PNCPLYVQIL
421 KPENKFHIKF ADHVVCEEEF KYAMLALNCI CPATSTLITL LVHTSRGQEG QQSPEQWQKM
481 YGRCSGNEVY HIVLEESTFF AEYEGKSFTY ASFHAHKKFG VCLIGVRRED NKNILLNPGP
541 RYIMNSTDIC FYINITKEEN SAFKNQDQQR KSNVSRSFYH GPSRLPVHSI IASMGTVAID
601 LQDTSCRSAS GPTLSLPTEG SKEIRRPSIA PVLEVADTSS IQTCDLLSDQ SEDETTPDEE
661 MSSNLEYAKG YPPYSPYIGS SPTFCHLLHE KVPFCCLRLD KSCQHNYYED AKAYGFKNKL
721 IIVAAETAGN GLYNFIVPLR AYYRPKKELN PIVLLLDNPP DMHFLDAICW FPMVYYMVGS
781 IDNLDDLLRC GVTFAANMVV VDKESTMSAE EDYMADAKTI VNVQTLFRLF SSLSIITELT
841 HPANMRFMQF RAKDCYSLAL SKLEKKERER GSNLAFMFRL PFAAGRVFSI SMLDTLLYQS
901 FVKDYMISIT RLLLGLDTTP GSGFLCSMKI TADDLWIRTY ARLYQKLCSS TGDVPIGIYR
961 TESQKLTTSE SQISISVEEW EDTKDSKEQG HHRSNHRNST SSDQSDHPLL RRKSMQWARR
1021 LSRKGPKHSG KTAEKITQQR LNLYRRSERQ ELAELVKNRM KHLGLSTVGY DEMNDHQSTL
1081 SYILINPSPD TRIELNDVVY LIRPDPLAYL PNSEPSRRNS ICNVTGQDSR EETQLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 3.5 nTPM
Expression across tissuesHPA
Tissue
- ovary: 3.5 nTPM
- blood vessel: 2.9 nTPM
- liver: 2.6 nTPM
- cerebral cortex: 2 nTPM
- lung: 1.7 nTPM
- heart muscle: 1.6 nTPM
Single-cell type
- epicardial cells: 1,151 nCPM
- mesothelial cells: 684 nCPM
- gonadotrophs: 603 nCPM
- bergmann glia: 583 nCPM
- thyrotrophs: 492 nCPM
- oligodendrocyte progenitor cells: 388 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 15 nTPM
- hippocampal formation: 13 nTPM
- basal ganglia: 11 nTPM
- cerebral cortex: 11 nTPM
- white matter: 8.3 nTPM
- spinal cord: 7.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KCNT2.
Disease | AllUniProt
Conditions KCNT2 is implicated in, by any mechanism.
- Developmental and epileptic encephalopathy 57 (DEE57) MIM:617771
Disease | GeneticClinVar
17 pathogenic / likely-pathogenic of 314 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental and epileptic encephalopathy, 57
- KCNT2-related disorder
- Seizure
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 3.56
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- intracellular sodium-activated potassium channel activity
- outward rectifier potassium channel activity
- chloride-activated potassium channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Regulator of K+ conductance, N-terminal lobe
- Calcium-activated potassium channel BK, alpha subunit
- Potassium channel domain
- NAD(P)-binding domain superfamily
- Calcium-activated potassium channel slowpoke-like
- Calcium-activated BK potassium channel alpha subunit
- Ion channel
- Calcium-activated potassium channel slowpoke-like RCK domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCNT2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNT2 as an antibody target. Whether an autoantibody or antibody against KCNT2 could matter depends on whether native KCNT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNT2 is annotated at the cell surface, where native KCNT2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...